| 产品名称 |
点击数 |
| Anti-Human CD178/FASLG/TNFSF6 Recombinant Antibody, PE|抗人CD178/FASLG/TNFSF6重组抗体,PE标记(靶标:Fas配体/CD178/TNFSF6) |
419 |
| Anti-Human CXCL12/SDF-1 Recombinant Antibody , PE|抗人CXCL12/SDF-1重组抗体,PE标记(靶标:CXC趋化因子配体12/基质细胞衍生因子1) |
375 |
| Anti-Human CD295/LEPR Recombinant Antibody , PE|抗人CD295/LEPR重组抗体,PE标记(靶标:瘦素受体/CD295) |
497 |
| Anti-Human CD151 Recombinant Antibody, PE|抗人CD151重组抗体,PE标记(靶标:CD151分子) |
479 |
| Anti-Human CD183/CXCR3 Recombinant Antibody, PE|抗人CD183/CXCR3重组抗体,PE标记(靶标:CXC趋化因子受体3/CD183) |
402 |
| Anti-Human CD183/CXCR3 Recombinant Antibody, PE|抗人CD183/CXCR3重组抗体,PE标记(靶标:CXC趋化因子受体3/CD183) |
454 |
| Anti-Human CD183/CXCR3 Recombinant Antibody, PE|抗人CD183/CXCR3重组抗体,PE标记(靶标:CXC趋化因子受体3/CD183) |
181 |
| Anti-Human CD183/CXCR3 Recombinant Antibody, PE|抗人CD183/CXCR3重组抗体,PE标记(靶标:CXC趋化因子受体3/CD183) |
187 |
| Anti-Human VEGFB Recombinant Antibody , PE|抗人VEGFB重组抗体,PE标记(靶标:血管内皮生长因子B) |
270 |
| Anti-Human Flt3 ligand/FLT3LG Recombinant Antibody , PE|抗人Flt3配体/FLT3LG重组抗体,PE标记(靶标:Fms相关酪氨酸激酶3配体) |
292 |
| Anti-Human CD39/ENTPD1 Recombinant Antibody, PE|抗人CD39/ENTPD1重组抗体,PE标记(靶标:外核苷酸三磷酸二磷酸水解酶1/CD39) |
147 |
| Anti-Human AGTR2/AT2 Recombinant Antibody, PE|抗人AGTR2/AT2重组抗体,PE标记(靶标:血管紧张素Ⅱ受体2型/AT2) |
123 |
| Anti-Human CD253/TNFSF10/TRAIL Recombinant Antibody , PE|抗人CD253/TNFSF10/TRAIL重组抗体,PE标记(靶标:肿瘤坏死因子配体超家族成员10/TRAIL/CD253) |
434 |
| Anti-Human CD239/BCAM Recombinant Antibody, PE|抗人CD239/BCAM重组抗体,PE标记(靶标:基底细胞黏附分子/CD239) |
157 |
| Anti-Human GPC3 Recombinant Antibody , PE|抗人GPC3重组抗体,PE标记(靶标:磷脂酰肌醇蛋白聚糖3) |
126 |
| Anti-Human CCL11/Eotaxin Recombinant Antibody , PE|抗人CCL11/嗜酸粒细胞趋化因子重组抗体,PE标记(靶标:CC趋化因子配体11/嗜酸粒细胞趋化因子) |
420 |
| Anti-Human CD193/CCR3 Recombinant Antibody, PE|抗人CD193/CCR3重组抗体,PE标记(靶标:CC趋化因子受体3/CD193) |
458 |
| Anti-Human CD194/CCR4 Recombinant Antibody , PE|抗人CD194/CCR4重组抗体,PE标记(靶标:CC趋化因子受体4/CD194) |
149 |
| Anti-Human CD195/CCR5 Recombinant Antibody, PE|抗人CD195/CCR5重组抗体,PE标记(靶标:CC趋化因子受体5/CD195) |
397 |
| Anti-Human Sulfated CD195/CCR5 Recombinant Antibody, PE|抗人硫酸化CD195/CCR5重组抗体,PE标记(靶标:CC趋化因子受体5/CD195) |
273 |